High cholesterol: the numbers that matter and what to do about your real risk
Which cholesterol numbers matter in mmol/L and mg/dL, why you no longer need to fast, what lipoprotein(a) is, and when lifestyle is enough or not.
5 min readEducational content by RejuvelookUpdated in October 2026
In short
The cholesterol that matters most is LDL: it causes atherosclerosis and, the lower it goes, the fewer heart attacks and strokes. Routine tests no longer require fasting, and lipoprotein(a) is worth measuring at least once in life. Whether to rely on lifestyle or add medication depends on your overall cardiovascular risk, not a single number.
Key points
- A lipid profile can be taken without fasting: the changes after a normal meal are not clinically relevant.
- European guidelines recommend measuring lipoprotein(a) at least once in adult life.
- Every 1 mmol/L (39 mg/dL) reduction in LDL cholesterol cuts major vascular events by about 22%, with no threshold below which it stops helping.
- Your LDL target depends on your risk: from below 3.0 mmol/L (116 mg/dL) at low risk to below 1.4 mmol/L (55 mg/dL) at very high risk.
- One person in 313 has familial hypercholesterolaemia; with an LDL of 4.9 mmol/L (190 mg/dL) or more, it rises to one in 14.
A high cholesterol result is worrying, but the number alone says little. What matters is which fraction is high, what your cardiovascular risk is, and what has been shown to work for someone like you. This guide sets it out using current European guidelines, with numbers in both mmol/L, as UK and Nordic GPs report them, and mg/dL, as most Spanish labs do.
Which cholesterol matters
Cholesterol travels in the blood inside particles called lipoproteins. The ones that weigh most on your risk are LDL particles: they deposit cholesterol in artery walls and cause atherosclerosis. That is why LDL cholesterol is the main treatment target [3].
A full lipid profile includes total cholesterol, LDL, HDL and triglycerides. Non-HDL cholesterol and apolipoprotein B are sometimes added; they sharpen the estimate in people with high triglycerides or diabetes.
The blood test: no fasting, and lipoprotein(a)
For years you were told to fast. Routinely, you no longer need to. A 2016 European consensus found that after a normal meal the changes are small and clinically irrelevant: triglycerides rise by about 0.3 mmol/L (26 mg/dL) and LDL falls by about 0.2 mmol/L (8 mg/dL), while HDL and lipoprotein(a) do not change [1]. Only if non-fasting triglycerides are above 5 mmol/L (440 mg/dL) is the test repeated fasting [1].
Lipoprotein(a), or Lp(a), is the forgotten marker. It is a particle similar to LDL whose level depends mainly on your genes and changes little with lifestyle. A high level raises the risk of heart attack and of aortic valve narrowing, even when LDL is low. That is why the European Atherosclerosis Society and the European guidelines recommend measuring it at least once in adult life [2] [3]. Labs flag an Lp(a) of 50 mg/dL or more as raised, and above 150 mg/dL the risk is very high [1]. The 2025 update of the European guidelines strengthens its role in risk assessment [4].
Your risk comes before your number
The same LDL does not mean the same thing at 35 with no other risk factors as at 60 with diabetes and a smoking habit. European prevention guidelines estimate ten-year risk with SCORE2, and SCORE2-OP from 70 [5]. In the UK your GP will usually have used QRISK, so the percentages may not match.
That risk sets your LDL target [3]:
- Very high risk: below 1.4 mmol/L (55 mg/dL) and at least a 50% reduction.
- High risk: below 1.8 mmol/L (70 mg/dL).
- Moderate risk: below 2.6 mmol/L (100 mg/dL).
- Low risk: below 3.0 mmol/L (116 mg/dL).
What if you are already below target? The idea that going lower "adds nothing" does not hold up. A meta-analysis of 26 trials and 170,000 people showed that every 1 mmol/L (39 mg/dL) reduction in LDL cuts major vascular events by about 22%, with no threshold below which the benefit disappears [6]. The real question is how much absolute benefit each person gains, given their risk.
Familial hypercholesterolaemia: when to think of it
One person in 313 has an inherited form of high cholesterol that raises LDL from childhood. Among people with an LDL of 4.9 mmol/L (190 mg/dL) or more, that rises to one in 14 [7]. If that is you, or there are early heart attacks in your family, it deserves specific testing, and your close relatives should know.
What has evidence behind it
Lifestyle is the foundation for everyone: less saturated fat and ultra-processed food, more fibre, pulses, nuts and olive oil, regular activity and weight control. If your glucose or blood pressure is also raised, look at the bigger picture in our guide to metabolic syndrome.
When your risk justifies it, or LDL does not reach target with lifestyle alone, the doctor will consider cholesterol-lowering medication. It is among the most thoroughly studied treatments in medicine [6]. By contrast, the guidelines do not recommend supplements without documented safety and efficacy [4].
What the evidence says
Each statement shows its level of evidence and the sources behind it.
Supported
- Lowering LDL cholesterol reduces heart attacks, strokes and revascularisations in proportion to the reduction, with no known lower threshold.[6]High-quality evidence
- A non-fasting lipid profile is valid for routine assessment; fasting is kept for very high triglycerides.[1]High-quality evidence
- Lipoprotein(a) is a causal, largely genetic risk factor and should be measured at least once in adult life.[2][3]High-quality evidence
With caveats
Not enough support
- Supplements and nutraceuticals for cholesterol without documented safety and efficacy: not recommended by the guidelines.[4]Low-quality evidence
What to expect, realistically
With changes to diet and weight, LDL usually falls moderately, and the response varies a great deal between people because of genetics. If medication is started, its effect is checked with a blood test a few weeks later and adjusted until the target is reached.
Lp(a), by contrast, barely moves with lifestyle. It does not need routine repeating: it is measured once and taken into account when estimating your risk and deciding how tightly to control everything else [2].
Risks, and who this is not for
The biggest danger of high cholesterol is that it causes no symptoms. Equally, treating a number without looking at risk does not help: at low risk, lifestyle and monitoring are often enough. Medication, when indicated, is chosen and monitored for your case, and side effects are reviewed at follow-up.
How it works at Rejuvelook
Cholesterol is managed within our weight and metabolic health programme, online anywhere in Spain and in person in Fuengirola, in English or Spanish. It starts with a medical video consultation and, if needed, a blood test at a lab near you: no fasting, and with Lp(a) if you have never had it measured.
The doctor calculates your cardiovascular risk, agrees your LDL target with you and proposes a plan with regular reviews. Any medication is prescribed on a Spanish e-prescription and monitored, and reports are available in English for your GP at home. If the results point to familial hypercholesterolaemia or another problem that needs a specialist unit, we will guide you there. To see how this fits with weight, read our guide to medical weight loss in Spain.
When to see a doctor
Book a medical consultation, or go to A&E if it is severe or sudden, if you notice:
- Chest pain or tightness, breathlessness, sudden weakness or difficulty speaking: call 112 straight away.
- An LDL of 4.9 mmol/L (190 mg/dL) or more, or relatives who had heart attacks or strokes young: familial hypercholesterolaemia should be ruled out.
- Very high triglycerides, especially with severe abdominal pain: there is a risk of pancreatitis.
- Yellowish lumps on tendons or eyelids, or a pale ring around the cornea before the age of 45.
Frequently asked
My UK results are in mmol/L and the Spanish ones in mg/dL. How do I compare them?
For cholesterol, multiply mmol/L by about 38.7 to get mg/dL; for triglycerides, by about 88.6. This guide gives both. Bring your previous reports and the doctor will set them side by side.
My lipoprotein(a) result is in nmol/L. Is that the same?
It is the same marker in a different unit, and the conversion to mg/dL is only approximate. Bring the report: what matters is whether it is raised, and that is read against the lab's own reference.
How often should I have my cholesterol checked?
It depends on your risk and on whether anything is changing. After a change in habits or treatment, a recheck within weeks or months is usual; with stable numbers and low risk, much less often.
Does cholesterol in food, such as eggs, raise mine much?
For most people, less than saturated fat, excess weight or genetics. The doctor goes through what you actually eat before suggesting changes.
If I start treatment, is it for life?
Your cardiovascular risk does not disappear when cholesterol falls, so the benefit depends on keeping it down. It is reviewed with you regularly and adjusted if your risk or habits change.
Can I be followed up online?
Yes. The programme runs online anywhere in Spain, in English or Spanish, with blood tests at a lab near you, and in person in Fuengirola.
References
Sources checked against PubMed or Crossref. Cited as plain text, without links.
- 1.Nordestgaard BG, Langsted A, Mora S, Kolovou G, Baum H, Bruckert E, et al. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J. 2016;37(25):1944-58. doi: 10.1093/eurheartj/ehw152. PMID: 27122601.Verified on 2 October 2026
- 2.Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43(39):3925-3946. doi: 10.1093/eurheartj/ehac361. PMID: 36036785.Verified on 2 October 2026
- 3.Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111-188. doi: 10.1093/eurheartj/ehz455. PMID: 31504418.Verified on 2 October 2026
- 4.Mach F, Koskinas KC, Roeters van Lennep JE, Tokgözoğlu L, Badimon L, Baigent C, et al. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2025;46(42):4359-4378. doi: 10.1093/eurheartj/ehaf190. PMID: 40878289.Verified on 2 October 2026
- 5.Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484. PMID: 34458905.Verified on 2 October 2026
- 6.Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670-81. doi: 10.1016/S0140-6736(10)61350-5. PMID: 21067804.Verified on 2 October 2026
- 7.Beheshti SO, Madsen CM, Varbo A, Nordestgaard BG. Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects. J Am Coll Cardiol. 2020;75(20):2553-2566. doi: 10.1016/j.jacc.2020.03.057. PMID: 32439005.Verified on 2 October 2026
Educational content. It does not replace a medical consultation or provide a diagnosis. Tests and treatments are indicated only after medical consultation and in line with regulation.